Edward Norbert Van Den Brink,Joost J. Neijssen,Aran Frank Labrijn,Joyce Meesters,Janine Schuurman,Isil Altintas,Paul Parren,Rik Rademaker
申请号:
US15110414
公开号:
US10407501B2
申请日:
2015.01.08
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The present invention relates to humanized or chimeric antibodies binding CD3. It furthermore relates to bispecific antibodies, compositions, pharmaceutical compositions, use of said antibodies in the treatment of a disease, and method of treatment.